Drug Profile
Desloratadine - Hefei Industrial Pharmaceutical Institute
Alternative Names: Desloratadine citrate disodiumLatest Information Update: 24 Nov 2021
Price :
$50
*
At a glance
- Originator Hefei Industrial Pharmaceutical Institute
- Class Antiallergics; Dibenzocycloheptenes; Nonsedating antihistamines; Piperidines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Allergic rhinitis
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for preclinical development in Allergic-rhinitis in China (Parenteral, Injection)
- 31 Dec 2015 Preclinical trials in Allergic rhinitis in China (Parenteral)